<DOC>
	<DOCNO>NCT01584986</DOCNO>
	<brief_summary>Regeneration occlude peripheral artery autologous stem cell therapy emerge treatment modality no-option patient peripheral artery disease ( PAD ) . The purpose study assess safety efficacy ex vivo expand , peripheral blood-derived , autologous angiogenic cell precursor ( ACPs ) no-option PAD patient .</brief_summary>
	<brief_title>Autologous Angiogenic Cell Precursors ( ACPs ) Treatment Peripheral Artery Disease</brief_title>
	<detailed_description>Late-stage no-option PAD patient high risk amputation affect limb enrol randomize treat control group . In 10 ACP treat patient stem cell inject ischemic gastrocnemius muscle . The 10 control patient treat conventional therapy . Physical examination , treadmill walk test perform , ankle brachial index ( ABI ) , transcutaneous oxygen pressure ( TcO2 ) measure baseline , 1 3 month later . Digital substraction angiography SF-36 quality-of-life ( QoL ) questionnaire also perform baseline 3 month later .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Subjects one clinical indication diagnostic CLI : distal extremity pain rest require subject use analgesic &gt; 2 week ; peripheral ischemic ulcer ( ) ; area gangrene ; nonhealing ischemic ulcer ; Subjects one follow hemodynamic indicator severe peripheral arterial occlusive disease : I. Ankle brachial index ≤ 0.45 II . Toe brachial index ≤ 0.35 III . TcPO2 / TcO2 ≤ 40 mmHg . The subject poor candidate standard revascularization treatment option peripheral arterial disease , base inadequate bypass conduit , unfavorable anatomy ; Age 18 80 year ; Male nonpregnant , nonlactating female ; Informed consent obtain consent form sign . Patient angiography meaningful suprapopliteal occlusion may relate symptom CLI ; Subjects , opinion investigator , vascular disease prognosis indicate would require major amputation ( ankle ) within 4 week start treatment ; Patient receive blood transfusion previous 4 week ( exclude potential nonautologous ACPs harvest blood ) ; Inability communicate ( may interfere clinical evaluation patient ) ; Major operation precede 3 month ; Myocardial infarction brain infarction uncontrolled myocardial ischemia persistent severe heart failure ( EF &lt; 25 % ) precede 3 month ; Significant valvular disease valve replacement ; After heart transplantation ; Cardiomyopathy ; Renal failure ( creatinine &gt; 2 mg/dl ) ; Hepatic failure ; Anemia ( low 11 mg/dl hemoglobin female low 12 mg/dl male ) ; Abnormal coagulation test [ platelet , PT ( INR ) , PTT ] ; Stroke within precede 3 year ; Malignancy within precede 3 year ; Concurrent chronic acute infectious disease ; Severe concurrent medical disease ( e.g. , septicemia , HIV1,2/HBV/HCV infection , poorly control insulindependent diabetes mellitus ; HbAlc &gt; 8 % proliferative retinopathy , systemic lupus erythematosus , multiple sclerosis , amyotrophic lateral sclerosis ) ; Chronic immunomodulating cytotoxic drug treatment ; Patients rectal temp . 38.4 ºC 2 consecutive day ; Patient unlikely available followup .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>